SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is currently facing intense community debate as investors weigh the firm's aggressive dilution strategy against the impact of recent Bitcoin price volatility and external macro pressures. Market participants are actively scrutinizing the company's high-leverage business model, with ongoing discussions polarized between those anticipating a major liquidation risk and others viewing the stock's recent weakness as a prime opportunity for accumulation.

BRC Group Holdings, Inc. engages in the provision of financial services and solutions to the capital raising and financial advisory needs of public and private firms. It operates through the following segments: Capital Markets, Wealth Management, Financial Consulting, Auction and Liquidation, Communications, and Consumer. The Capital Markets segment provides investment banking, corporate finance, research, wealth management, and sales and trading services to corporate, institutional, and high net worth clients. The Wealth Management segment offers retail brokerage, investment management, and insurance, and tax preparation services. The Financial Consulting segment focuses on a variety of specialized advisory services spanning bankruptcy, restructuring, turnaround management, forensic accounting, crisis and litigation support, appraisal and valuation, real estate, and operations management. The Auction and Liquidation segment deals with retail liquidation services. The Communications segment is composed of a portfolio of companies acquired for attractive risk-adjusted investment return characteristics. The Consumer segment includes Targus and the Brands investment portfolio. The company was founded in 1973 and is headquartered in Los Angeles, CA.

BRC Group Holdings Inc.

B. Riley Financial Inc

B. Riley Financial is trending as investors debate the impact of a short-seller report on its primary holdings and the company's delayed 10-K filing. Despite volatility and bearish pressure, the community remains divided, with many long-term holders viewing the pullback as a buying opportunity ahead of anticipated debt reduction and earnings results.

"What's Updog?" is a Community Led token.

UpDog

UpDog is generating significant buzz as community members rally behind the meme-themed token, frequently sharing its contract address and encouraging others to join through active engagement on social platforms. While supporters highlight the community's longevity and thematic humor, detractors have surfaced concerns regarding the project's legitimacy and volatility.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is generating intense community buzz as investors brace for the late-breaking presentation of 40-week VELA trial data at the upcoming American Academy of Dermatology annual meeting. The stock is seeing significant institutional accumulation and analyst upgrades, with shareholders actively debating the potential for a transformative buyout as the company solidifies its position as a best-in-class leader in the hidradenitis suppurativa treatment landscape.

Apellis Pharmaceuticals, Inc. is a commercial-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs. Its products include EMPAVELI and SYFOVRE. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, and Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.

Apellis Pharmaceuticals Inc

Apellis Pharmaceuticals is trending following the FDA approval of EMPAVELI for the treatment of rare kidney diseases, C3G and primary IC-MPGN. Investors are actively discussing the potential impact of this label expansion on long-term revenue growth and its role in bolstering the company's position as a buyout candidate, while monitoring how this news might trigger a short squeeze given the stock's high short interest.

WeShop Holdings Ltd. engages in providing a shoppable social network. It offers shopping in fashion and accessories, health and beauty, home and DIY, food and drink, travel and holidays, tech and electronics, and other popular categories. It includes a library of shoppable product reviews from a digital online shopping mall on mobile devices. The company was founded by John Garner on September 21, 2012 and is headquartered in Jersey, the United Kingdom.

WeShop Holdings Ltd - Ordinary Shares - Class A

WeShop Holdings Limited

WeShop Holdings is seeing intense retail activity as traders speculate on a potential short squeeze fueled by an exceptionally tight public float and high borrow rates. The community remains deeply divided, with bulls betting on explosive price volatility similar to past market runners, while bears warn of a pump-and-dump scheme driven by lack of institutional support and low trading volumes.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is experiencing high volatility as the community debates whether the stock is a long-term AI infrastructure play or an overextended trade susceptible to profit-taking. Investors are actively discussing support levels and the impact of sector-wide pressure, while some highlight potential acquisition rumors or long-term growth as catalysts for future price action.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is currently a focal point for community discussion as traders debate its resilience amidst broader crypto market volatility and the rise of experimental tokens within its ecosystem. While some participants express concern over price fluctuations, others remain focused on developer momentum, institutional adoption, and the potential for long-term growth as a core infrastructure layer in decentralized finance.

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending as investors debate a potential proxy fight initiated by activist investor Shah Capital, while simultaneously scrutinizing the departure of its Head of R&D and the company's ongoing struggle with short interest. The community remains sharply divided between those calling for an immediate leadership overhaul or corporate buyout to unlock value, and long-term holders banking on a potential gamma squeeze driven by high call options volume and limited share availability.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is facing a sharp sell-off driven by investor concerns over cyclical memory pricing, potential AI demand shifts following industry reports on efficiency, and broad semiconductor distribution. While the community is deeply polarizeddebating whether this is a structural re-rating or a manipulative short trapmany traders are actively monitoring the stock's failure to rebound alongside broader market rallies while watching for key support levels.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$MU  
 
Here are the analyst updates I have seen so far this morning for Micron: 
 
KeyBanc &#39;disappointed&#39; with Micron results but stays Overweight 
 
KeyBanc keeps an Overweight rating on Micron with a $135 price target following last night&#39;s fiscal Q1 results. The company reported in line results but guided Q2 meaningfully below expectations, the analyst tells investors in a research note. The firm says the weak outlook was attributed to a pause in demand in data center solid-state drives, slower than expected inventory digestion in consumer, and industry oversupply of NAND. KeyBanc is &quot;disappointed&quot; in the results and lowered estimates, but it encouraged by the progress and ramp of HBM3e and long-term secular industry tailwinds for Micron. 
 
 
Micron price target lowered to $140 from $175 at Wells Fargo  
 
Wells Fargo lowered the firm&#39;s price target on Micron to $140 from $175 and keeps an Overweight rating on the shares following the fiscal Q1 report. The firm says that while it is tough to argue against the weaker Q2 outlook driven selloff, Micron&#39;s data center-driven thesis is unchanged. Wells reduced estimates following the report, noting consumer weakness is outweighing continued data center strength. 
 
 
Micron downgraded to Neutral at BofA on extended pricing pressure 
 
BofA downgraded Micron to Neutral from Buy with a price target of $110, down from $125. The firm, whose estimates were below consensus heading into Q1 results, is reducing estimates again as gross margin is expected to stay weak in Q2 and even Q3, the analyst tells investors. Data center and HBM trends remain strong, but weakness in PC and phone markets are putting downward pressure on memory pricing, especially in NAND, the analyst added. 
 
 
Micron price target lowered to $140 from $175 at Wells Fargo  
 
Wells Fargo analyst Aaron Rakers lowered the firm&#39;s price target on Micron to $140 from $175 and keeps an Overweight rating on the shares. While the firm says its datacenter-driven positive thesis is unchanged, it&#39;s &quot;tough&quot; to argue against the weaker Q2-driven selloff in the shares, the analyst tells investors in a research note. Wells says it &quot;underestimated&quot; the consumer-driven inventory correction. 
 
 
Micron price target lowered to $110 from $145 at Barclays  
 
Barclays analyst Tom O&#39;Malley lowered the firm&#39;s price target on Micron to $110 from $145 and keeps an Overweight rating on the shares. The company&#39;s &quot;material miss&quot; despite improving high-bandwidth memory commentary will have investors worried that the cycle is turning despite some secular growth, the analyst tells investors in a research note. The firm says the NAND weakness was expected but the sequential decline in DRAM &quot;will have investors worried.&quot; Barclays believes Micron&#39;s commentary on slowing tech transitions and weakening fundamentals despite the better HBM data points will likely be an ongoing issue for the stock. 
 
 
Micron price target lowered to $145 from $180 at JPMorgan  
 
JPMorgan lowered the firm&#39;s price target on Micron to $145 from $180 and keeps an Overweight rating on the shares. The company reported in-line November quarter revenue while earnings were modestly above expectations as robust DRAM bit shipments and a high-single-digit improvements in DRAM pricing offset weakness in NAND bit shipments and pricing, the analyst tells investors in a research note. However, the firm says Micron&#39;s February quarter revenue was guided down 9% quarter-over-quarter and came in well below expectations as excess inventory and sluggish demand across consumer facing end markets are anticipated to be a substantial headwind to NAND bit shipments. JPMorgan cut estimates but believes the stock setup for the second half of 2025 remains positive. 
 
 
Citi stays Buy on Micron despite worse than expected guidance 
 
Citi says Micron reported strong results but guided below the firm&#39;s recently-lowered estimates as the weakness in NAND and excess DRAM inventory in the PC and handset end markets is worse than previewed. However, Citi continues to believe the DRAM inventory correction should finish by the Spring as it has been occurring for several months and DRAM companies are lowering capex and production. It lowered estimates but reiterates a Buy rating and $150 price target on Micron. 
 
 
Micron price target lowered to $130 from $150 at Baird 
 
Baird lowered the firm&#39;s price target on Micron to $130 from $150 and keeps an Outperform rating on the shares following last night&#39;s results. Micron&#39;s outlook, notably in NAND, reflects further and recent deterioration in macro trends from an already step down in demand over the summer, the analyst tells investors in a research note. The firm expects DRAM pricing to decline through mid-2025, driven by weakness in PCs and mobile, and slightly rebound in the second half of 2025. It believes Micron&#39;s high-bandwidth memory opportunity is not priced into the shares. 
 
 
Micron price target lowered to $125 from $135 at UBS 
 
UBS lowered the firm&#39;s price target on Micron to $125 from $135 and keeps a Buy rating on the shares. Micron&#39;s guidance was below the most bearish expectations into the report, with Micron citing ongoing malaise in consumer markets, the analyst tells investors in a research note. However, UBS sees numerous bright spots, saying the DRAM story is very good, and thinks the model sets up for a big &quot;hockey stick&quot; in revenue moving through the year. UBS sees the pullback as a buying opportunity. 
 
 
Micron price target lowered to $130 from $135 at Stifel  
 
Stifel analyst Brian Chin lowered the firm&#39;s price target on Micron to $130 from $135 and keeps a Buy rating on the shares after Micron reported inline fiscal Q1 results while guiding Q2 revenue and earnings lower quarter-over-quarter, missing the firm&#39;s and consensus estimates. The firm had expressed caution into the print given a belief that management would provide a more conservative outlook, but the magnitude of the miss was &quot;more severe than many anticipated,&quot; the analyst tells investors. However, Stifel continues to view this as a mid-cycle correction and noted management guided for memory bit shipments to re-accelerate in fiscal Q3 and Q4 following an OEM inventory digestion period. 
 
 
Micron price target lowered to $98 from $114 at Morgan Stanley 
 
Morgan Stanley analyst Joseph Moore lowered the firm&#39;s price target on Micron to $98 from $114 and keeps an Equal Weight rating on the shares. Micron guided Q2 revenue below expectations, driven mostly by revenue decline in NAND, notes the analyst, who is lowering estimates and sees AI growth as likely to be dragged down by commodity weakness. 
 
 
Micron price target lowered to $120 from $140 at Needham  
 
Needham lowered the firm&#39;s price target on Micron to $120 from $140 and keeps a Buy rating on the shares after its Q1 earnings. The company posted a slight beat, but guidance was well below as Consumer markets and Data Center SSD are weaker-than-expected over the near-term, the analyst tells investors in a research note. Micron&#39;s weakness is predominately being seen within NAND memory, and lower than previous industry bit demand growth is now expected in 2024 and 2025, the firm added.

Polkaface

Chad

Sir Pawl Meowrice Catson

DrOctagon

Todd

Suraj Mann

AceMoneyPicks

Investor Guy

Sinan

William Bruford

Stocktwits

cbcco

Sven Martin

Barry M

Wade

Naomi

GittHubster

BULAI NICOLAE

Newbie lvl 2.7

ethem atilla albayrak

Julie Peccedi

Mehedi hasan

Clayton Yates

Andy B

Bugsey

XxDarkSoulxX

Booboo

kbec

Dragos Vad

StockTwits for iOS

StockTwits Web

  
 
Here are the analyst updates I have seen so far this morning for Micron: 
 
KeyBanc 'disappointed' with Micron results but stays Overweight 
 
KeyBanc keeps an Overweight rating on Micron with a $135 price target following last night's fiscal Q1 results. The company reported in line results but guided Q2 meaningfully below expectations, the analyst tells investors in a research note. The firm says the weak outlook was attributed to a pause in demand in data center solid-state drives, slower than expected inventory digestion in consumer, and industry oversupply of NAND. KeyBanc is "disappointed" in the results and lowered estimates, but it encouraged by the progress and ramp of HBM3e and long-term secular industry tailwinds for Micron. 
 
 
Micron price target lowered to $140 from $175 at Wells Fargo  
 
Wells Fargo lowered the firm's price target on Micron to $140 from $175 and keeps an Overweight rating on the shares following the fiscal Q1 report. The firm says that while it is tough to argue against the weaker Q2 outlook driven selloff, Micron's data center-driven thesis is unchanged. Wells reduced estimates following the report, noting consumer weakness is outweighing continued data center strength. 
 
 
Micron downgraded to Neutral at BofA on extended pricing pressure 
 
BofA downgraded Micron to Neutral from Buy with a price target of $110, down from $125. The firm, whose estimates were below consensus heading into Q1 results, is reducing estimates again as gross margin is expected to stay weak in Q2 and even Q3, the analyst tells investors. Data center and HBM trends remain strong, but weakness in PC and phone markets are putting downward pressure on memory pricing, especially in NAND, the analyst added. 
 
 
Micron price target lowered to $140 from $175 at Wells Fargo  
 
Wells Fargo analyst Aaron Rakers lowered the firm's price target on Micron to $140 from $175 and keeps an Overweight rating on the shares. While the firm says its datacenter-driven positive thesis is unchanged, it's "tough" to argue against the weaker Q2-driven selloff in the shares, the analyst tells investors in a research note. Wells says it "underestimated" the consumer-driven inventory correction. 
 
 
Micron price target lowered to $110 from $145 at Barclays  
 
Barclays analyst Tom O'Malley lowered the firm's price target on Micron to $110 from $145 and keeps an Overweight rating on the shares. The company's "material miss" despite improving high-bandwidth memory commentary will have investors worried that the cycle is turning despite some secular growth, the analyst tells investors in a research note. The firm says the NAND weakness was expected but the sequential decline in DRAM "will have investors worried." Barclays believes Micron's commentary on slowing tech transitions and weakening fundamentals despite the better HBM data points will likely be an ongoing issue for the stock. 
 
 
Micron price target lowered to $145 from $180 at JPMorgan  
 
JPMorgan lowered the firm's price target on Micron to $145 from $180 and keeps an Overweight rating on the shares. The company reported in-line November quarter revenue while earnings were modestly above expectations as robust DRAM bit shipments and a high-single-digit improvements in DRAM pricing offset weakness in NAND bit shipments and pricing, the analyst tells investors in a research note. However, the firm says Micron's February quarter revenue was guided down 9% quarter-over-quarter and came in well below expectations as excess inventory and sluggish demand across consumer facing end markets are anticipated to be a substantial headwind to NAND bit shipments. JPMorgan cut estimates but believes the stock setup for the second half of 2025 remains positive. 
 
 
Citi stays Buy on Micron despite worse than expected guidance 
 
Citi says Micron reported strong results but guided below the firm's recently-lowered estimates as the weakness in NAND and excess DRAM inventory in the PC and handset end markets is worse than previewed. However, Citi continues to believe the DRAM inventory correction should finish by the Spring as it has been occurring for several months and DRAM companies are lowering capex and production. It lowered estimates but reiterates a Buy rating and $150 price target on Micron. 
 
 
Micron price target lowered to $130 from $150 at Baird 
 
Baird lowered the firm's price target on Micron to $130 from $150 and keeps an Outperform rating on the shares following last night's results. Micron's outlook, notably in NAND, reflects further and recent deterioration in macro trends from an already step down in demand over the summer, the analyst tells investors in a research note. The firm expects DRAM pricing to decline through mid-2025, driven by weakness in PCs and mobile, and slightly rebound in the second half of 2025. It believes Micron's high-bandwidth memory opportunity is not priced into the shares. 
 
 
Micron price target lowered to $125 from $135 at UBS 
 
UBS lowered the firm's price target on Micron to $125 from $135 and keeps a Buy rating on the shares. Micron's guidance was below the most bearish expectations into the report, with Micron citing ongoing malaise in consumer markets, the analyst tells investors in a research note. However, UBS sees numerous bright spots, saying the DRAM story is very good, and thinks the model sets up for a big "hockey stick" in revenue moving through the year. UBS sees the pullback as a buying opportunity. 
 
 
Micron price target lowered to $130 from $135 at Stifel  
 
Stifel analyst Brian Chin lowered the firm's price target on Micron to $130 from $135 and keeps a Buy rating on the shares after Micron reported inline fiscal Q1 results while guiding Q2 revenue and earnings lower quarter-over-quarter, missing the firm's and consensus estimates. The firm had expressed caution into the print given a belief that management would provide a more conservative outlook, but the magnitude of the miss was "more severe than many anticipated," the analyst tells investors. However, Stifel continues to view this as a mid-cycle correction and noted management guided for memory bit shipments to re-accelerate in fiscal Q3 and Q4 following an OEM inventory digestion period. 
 
 
Micron price target lowered to $98 from $114 at Morgan Stanley 
 
Morgan Stanley analyst Joseph Moore lowered the firm's price target on Micron to $98 from $114 and keeps an Equal Weight rating on the shares. Micron guided Q2 revenue below expectations, driven mostly by revenue decline in NAND, notes the analyst, who is lowering estimates and sees AI growth as likely to be dragged down by commodity weakness. 
 
 
Micron price target lowered to $120 from $140 at Needham  
 
Needham lowered the firm's price target on Micron to $120 from $140 and keeps a Buy rating on the shares after its Q1 earnings. The company posted a slight beat, but guidance was well below as Consumer markets and Data Center SSD are weaker-than-expected over the near-term, the analyst tells investors in a research note. Micron's weakness is predominately being seen within NAND memory, and lower than previous industry bit demand growth is now expected in 2024 and 2025, the firm added.

Microsoft Corp

iShares Russell 2000 ETF

iShares 20+ Year Treasury Bond ETF

Alphabet Inc Class A

DonCorleone77

@DonCorleone77 as I mentioned this move lower absurd!

Stockgob

Dmoney

Coinbase Global Inc

D-Wave Quantum Inc

@DonCorleone77 the lowest target price is 98 from morgan stanley. Yet, itseems quite far. Let&#39;s hope we reach that by end of this year.

 the lowest target price is 98 from morgan stanley. Yet, itseems quite far. Let's hope we reach that by end of this year.

Adobe Inc

Super Micro Computer Inc

Palantir Technologies Inc

PayPal Holdings Inc

Block Inc

@DonCorleone77 Thanks. Most seem logical, a few overdone.

 Thanks. Most seem logical, a few overdone.

Landbridge Company LLC

Texas Pacific Land Corporation

United Airlines Holdings Inc

Po Scrip

@DonCorleone77 Great collection all in one post, thank you!

StockTwits For Android 

 Great collection all in one post, thank you!

VanEck Semiconductor ETF

Advanced Micro Devices Inc

Direxion Daily Semiconductor Bull 3X Shares

iShares Semiconductor ETF

@DonCorleone77  thanks for value added information

Insignia Systems, Inc.

U.S. Energy Corp.

iPower Inc

SUNation Energy Inc

XpresSpa Group Inc

My Size Inc

Urban One Inc

Cns Pharmaceuticals Inc

Muhammad Wahla

Sanjay

Netflix Inc

Chipotle Mexican Grill

Salesforce Inc

Nike Inc

Unitedhealth Group Inc

Telus Corp.

ServiceNow Inc

@DonCorleone77 Always appreciate your fact driven and pragmatic posts.

 Always appreciate your fact driven and pragmatic posts.

Lumen Technologies Inc

iShares Silver Trust

Bitmine Immersion Technologies Inc

Defiance Daily Target 2x Short PLTR ETF

@GittHubster  
 
Thank you very much Gitt. I am very happy if the posts are useful to you.